Virtus ETF Advisers LLC Belite Bio, Inc Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Belite Bio, Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,122 shares of BLTE stock, worth $75,667. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,122
Previous 1,843
39.12%
Holding current value
$75,667
Previous $86,000
18.6%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding BLTE
# of Institutions
22Shares Held
280KCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY168KShares$11.3 Million0.15% of portfolio
-
State Street Corp Boston, MA20KShares$1.35 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC18.3KShares$1.24 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY14.6KShares$987,0510.0% of portfolio
-
Ubs Group Ag12.2KShares$823,2400.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.68B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...